NCT01004991
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Weill Cornell Medical College New York, United States
Clinical trial condition
Diffuse Large B Cell Lymphoma
Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
165 public trials
52 recruiting studies
Diffuse Large B Cell Lymphoma trial results
NCT01715961
- Conditions
- Atrophy, Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, +19 more
- Locations
-
- Centre Henri Becquerel Rouen, France
NCT01314014
- Conditions
- Burkitt Lymphoma, Burkitt's Lymphoma, Chronic Disease, +34 more
- Locations
-
- Arizona Cancer Center, University of Arizona Tucson, Arizona, United States
- University of Rochester Medical Center Rochester, New York, United States
NCT01459887
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- SUN-YAT-SEN university cancer center Guangzhou, Guangdong, China
- Conditions
- Blood-Borne Infections, Communicable Diseases, Diffuse Large B Cell Lymphoma, +22 more
- Locations
-
- H. Son Llatzer Palma de Mallorca, Balearic Islands, Spain
- Germans Trias i Pujol Badalona, Barcelona, Spain
- H. Clínic i Provincial, Barcelona Barcelona, Spain
- H. Vall d'Hebron, Barcelona Barcelona, Spain
Active, Not Recruiting
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
NCT06323447
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B Cell Lymphoma, +18 more
- Locations
-
- University of Hawaii Cancer Center Honolulu, Hawaii, United States
- Norton Healthcare Cancer Center Louisville, Kentucky, United States
- Massachussetts General Hospital Boston, Massachusetts, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
Active, Not Recruiting
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
NCT05725720
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute Of Hematology "Seràgnoli" Bologna, Italy
Active, Not Recruiting
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
NCT05665062
- Conditions
- CLL/SLL, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +17 more
- Locations
-
- City of Hope Duarte, California, United States
- Roswell Park Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Cleveland Clinic Cleveland, Ohio, United States
Active, Not Recruiting
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
NCT04542824
- Conditions
- Chronic Disease, Diffuse Large B Cell Lymphoma, Disease Attributes, +25 more
- Locations
-
- Tohoku University Hoaspital Sendai, Miyagi, Japan
- Aichi Cancer Center Hospital Aichi, Japan
- NHO Nagoya Medical Center Aichi, Japan
- National Cancer Center Hospital East Chiba, Japan
Active, Not Recruiting
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
NCT03681535
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital Weymouth, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States